Keywords: Hailey-Hailey disease; benign chronic pemphigus; clinical case report; dupilumab; genetic skin disorder; inflammatory skin disease; monoclonal antibody; recalcitrant skin condition; skin barrier dysfunction; targeted biologic therapy.